Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James Rubenstein, MD, PhD
University of California, San Francisco
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucsf Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
- Tunnell Cancer Center at Beebe Medical Center
Lewes, Delaware, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Fort Wayne Medical Oncology and Hematology
Fort Wayne, Indiana, United States
- Hematology Oncology Associates of the Quad Cities
Bettendorf, Iowa, United States
- Menorah Medical Center
Overland Park, Kansas, United States
- Saint Luke'S Hospital - South
Overland Park, Kansas, United States
- Shawnee Mission Medical Center
Shawnee Mission, Kansas, United States
- Union Hospital Cancer Program at Union Hospital
Elkton MD, Maryland, United States
- Masonic Cancer Center at University of Minnesota
Minneapolis, Minnesota, United States
- Ccop - Kansas City
Kansas City, Missouri, United States
- North Kansas City Hospital
Kansas City, Missouri, United States
- Parvin Radiation Oncology
Kansas City, Missouri, United States
- Research Medical Center
Kansas City, Missouri, United States
- Saint Luke'S Cancer Institute at Saint Luke'S Hospital
Kansas City, Missouri, United States
- St. Joseph Medical Center
Kansas City, Missouri, United States
- Truman Medical Center - Hospital Hill
Kansas City, Missouri, United States
- Saint Luke'S East - Lee'S Summit
Lee's Summit, Missouri, United States
- Liberty Hospital
Liberty, Missouri, United States
- Heartland Regional Medical Center
Saint Joseph, Missouri, United States
- Cancer Institute of New Jersey at Cooper - Voorhees
Voorhees Township, New Jersey, United States
- Stony Brook University Cancer Center
Stony Brook, New York, United States
- Suny Upstate Medical University Hospital
Syracuse, New York, United States
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Columbus, Ohio, United States
- Miriam Hospital
Providence, Rhode Island, United States
- Rhode Island Hospital Comprehensive Cancer Center
Providence, Rhode Island, United States
- Mountainview Medical
Berlin Corners, Vermont, United States
- Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont, United States
- Danville Regional Medical Center
Danville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2004
- Primary completion
- 31 Jan 2010
- Completion
- 30 Sept 2014
- Last update posted
- 6 Jul 2016
- Registered enrollment
- 47
- Registry id
- NCT00098774
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.